Condition
Malignant Mesothelioma
Estimated Enrollment: 29
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: MESOT-TREM-2008|2008-005171-95
Study First Received: July 18, 2012
Last Updated: July 20, 2012
Estimated Primary Completion Date: June 2012
Primary Outcome Measures:
Objective tumor response by modified Response Evaluation Criteria in Solid Tumor (RECIST)|Disease control rate|Progression free survival|Safety
Sponsors and Collaborators:
Azienda Ospedaliera Universitaria Senese
Website Link: https://ClinicalTrials.gov/show/NCT01649024
